Independence Group NL – Mineral Resources and Ore Reserves Update

sunrise processing plant jaguar

Mineral Resources and Ore Reserves Annual update & Update on Exploration activities for the FY18: Independence Group NL (ASX: IGO) stock rose 0.62% on July 26, 2018 after the company provided the annual update of their Mineral Resources and Ore Reserves & update on Exploration activities for the FY18. IGO’s Nova Operation shows that 96% of the Mineral Resource is now classified as Measured and 92% of the Ore Reserve is classified as Proved. These are the highest confidence JORC Code categories of the project, and reflect a significant step in de-risking future production from Nova. IGO’s total Mineral Resources as at 30th June 2018, from all operations, includes combined estimated metal contents of 300kt Ni, 109kt Cu, 9kt Co, and 2.2Moz Au. IGO’s total Ore Reserves as at 30 June 2018 contained estimated metal contents of 216kt Ni, 89kt Cu, 7kt Co and 1.2Moz Au. The company has completed substantially all of the life-of-mine grade control drilling over the Nova and Bollinger deposits. Now, underground drilling at Nova is focusing on exploration drilling targeting additional orebodies at Nova. Further, at Tropicana, the company has completed Boston Shaker drilling and prefeasibility work is progressing as per schedule. The results to-date are encouraging and the study schedule is on track for delivery of an updated Mineral Resource and Ore Reserve for Boston Shaker by end of CY18. Meanwhile, IGO is managing the exploration activities on the Lake Mackay Joint Venture and has shown encouraging results. The follow-up rock chip samples from Grimlock Prospect has confirmed high Manganese (Mn)-Nickel (Ni)-Cobalt (Co) in outcrops with results up to 2.5% Co, 1.1% Ni, 46.4% Mn. IGO has commenced spectrem airborne EM survey with two blocks completed and the target generation in progress. On the other hand, IGO stock has fallen 8.38% in three months as on July 25, 2018.

[pluginops_form template_id=’23834′ ]


Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report